$NBIX
NEUROCRINE BIOSCIENCES INC

2022 Q4 Form 10-Q Financial Statement

#000091447522000058 Filed on November 01, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $412.0M $387.9M
YoY Change 32.05% 31.05%
Cost Of Revenue $7.700M $6.100M
YoY Change 87.8% 45.24%
Gross Profit $404.3M $381.8M
YoY Change 31.31% 30.84%
Gross Profit Margin 98.13% 98.43%
Selling, General & Admin $182.9M $186.3M
YoY Change 16.87% 20.5%
% of Gross Profit 45.24% 48.8%
Research & Development $118.0M $107.7M
YoY Change 35.01% 16.18%
% of Gross Profit 29.19% 28.21%
Depreciation & Amortization $4.400M $4.000M
YoY Change 46.67% 42.86%
% of Gross Profit 1.09% 1.05%
Operating Expenses $300.9M $294.0M
YoY Change 23.37% 18.88%
Operating Profit $103.4M $87.80M
YoY Change 61.56% 97.3%
Interest Expense $14.50M $1.200M
YoY Change -35.56% -81.82%
% of Operating Profit 14.02% 1.37%
Other Income/Expense, Net $10.10M
YoY Change -172.14%
Pretax Income $117.9M $97.90M
YoY Change -954.35% 220.98%
Income Tax $28.90M $29.40M
% Of Pretax Income 24.51% 30.03%
Net Earnings $89.00M $68.50M
YoY Change -1319.18% 204.44%
Net Earnings / Revenue 21.6% 17.66%
Basic Earnings Per Share $0.72
Diluted Earnings Per Share $0.88 $0.69
COMMON SHARES
Basic Shares Outstanding 96.13M shares 95.64M shares
Diluted Shares Outstanding 99.00M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $989.3M $799.4M
YoY Change 39.08% 4.37%
Cash & Equivalents $262.9M $212.2M
Short-Term Investments $726.4M $587.2M
Other Short-Term Assets $79.10M $67.90M
YoY Change 73.85% 34.46%
Inventory $35.10M $37.00M
Prepaid Expenses
Receivables $350.0M $301.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.454B $1.206B
YoY Change 49.41% 19.87%
LONG-TERM ASSETS
Property, Plant & Equipment $58.60M $60.90M
YoY Change 0.0% 19.18%
Goodwill $5.400M
YoY Change
Intangibles $37.20M
YoY Change
Long-Term Investments $401.5M $457.5M
YoY Change -35.7% -16.67%
Other Assets $25.00M $10.50M
YoY Change 468.18% 228.13%
Total Long-Term Assets $915.2M $937.9M
YoY Change -16.78% -7.29%
TOTAL ASSETS
Total Short-Term Assets $1.454B $1.206B
Total Long-Term Assets $915.2M $937.9M
Total Assets $2.369B $2.143B
YoY Change 14.29% 6.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $347.6M $297.8M
YoY Change 53.94% 44.63%
Accrued Expenses $17.40M $17.30M
YoY Change 5.45% 11.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $169.2M
YoY Change
Long-Term Debt Due $169.4M $169.2M
YoY Change
Total Short-Term Liabilities $537.7M $485.1M
YoY Change 118.76% 114.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $29.70M $17.10M
YoY Change 141.46% 106.02%
Total Long-Term Liabilities $29.70M $17.10M
YoY Change 141.46% 106.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $537.7M $485.1M
Total Long-Term Liabilities $29.70M $17.10M
Total Liabilities $660.9M $598.8M
YoY Change -5.38% -10.8%
SHAREHOLDERS EQUITY
Retained Earnings -$406.8M -$495.8M
YoY Change -36.02% -21.11%
Common Stock $2.123B $2.054B
YoY Change 5.52% 4.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.708B $1.545B
YoY Change
Total Liabilities & Shareholders Equity $2.369B $2.143B
YoY Change 14.29% 6.25%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income $89.00M $68.50M
YoY Change -1319.18% 204.44%
Depreciation, Depletion And Amortization $4.400M $4.000M
YoY Change 46.67% 42.86%
Cash From Operating Activities $143.0M $98.80M
YoY Change 3304.76% 59.87%
INVESTING ACTIVITIES
Capital Expenditures $1.800M $1.700M
YoY Change -120.22% -129.82%
Acquisitions
YoY Change
Other Investing Activities -$113.8M -$63.00M
YoY Change -449.08% -47.72%
Cash From Investing Activities -$115.6M -$61.30M
YoY Change -587.76% -51.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.60M 11.40M
YoY Change 1266.67% 52.0%
NET CHANGE
Cash From Operating Activities 143.0M 98.80M
Cash From Investing Activities -115.6M -61.30M
Cash From Financing Activities 24.60M 11.40M
Net Change In Cash 52.00M 48.90M
YoY Change 75.08% -185.94%
FREE CASH FLOW
Cash From Operating Activities $143.0M $98.80M
Capital Expenditures $1.800M $1.700M
Free Cash Flow $141.2M $97.10M
YoY Change 977.86% 43.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000914475
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2021Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P13Y7M
CY2021Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-22705
dei Entity Registrant Name
EntityRegistrantName
NEUROCRINE BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
12780 El Camino Real
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0525145
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
(858)
dei Local Phone Number
LocalPhoneNumber
617-7600
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
NBIX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
96134388 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212200000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
340800000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
587200000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
370500000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
301200000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
185500000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
37000000.0 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
30500000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
67900000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
45500000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1205500000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
972800000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
319400000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
315100000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
362600000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
560700000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89600000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
97200000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
94900000 usd
CY2021Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
63700000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60900000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58600000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10500000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4400000 usd
CY2022Q3 us-gaap Assets
Assets
2143400000 usd
CY2021Q4 us-gaap Assets
Assets
2072500000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
297800000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
225800000 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
169200000 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18100000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20000000.0 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
485100000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
245800000 usd
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2021Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
335100000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96600000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
105300000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17100000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12300000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
598800000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
698500000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2072500000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
220000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96100000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96100000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
94900000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
94900000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
100000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2054300000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2011400000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000000.0 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1700000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-495800000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-635800000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1544600000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1374000000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2143400000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
387900000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
296000000.0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1076700000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
821500000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6100000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4200000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15500000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10200000 usd
CY2022Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
107700000 usd
CY2021Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
92700000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
345800000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
240700000 usd
CY2022Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
CY2021Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
5000000.0 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
186300000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
154600000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
569800000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
426800000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
300100000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
251500000 usd
us-gaap Costs And Expenses
CostsAndExpenses
931100000 usd
us-gaap Costs And Expenses
CostsAndExpenses
682700000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
87800000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
44500000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
145600000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
138800000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1200000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
6600000 usd
us-gaap Interest Expense
InterestExpense
6000000.0 usd
us-gaap Interest Expense
InterestExpense
19200000 usd
CY2022Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
11100000 usd
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-8200000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
23600000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-7500000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-70000000.0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
200000 usd
CY2021Q3 nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
800000 usd
nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
2800000 usd
nbix Investment Income And Other Net
InvestmentIncomeAndOtherNet
3100000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10100000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14000000.0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49600000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23600000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
97900000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30500000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
96000000.0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
115200000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29400000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000000.0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30500000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18300000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
68500000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
22500000 usd
us-gaap Net Income Loss
NetIncomeLoss
65500000 usd
us-gaap Net Income Loss
NetIncomeLoss
96900000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1800000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-300000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-12300000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1400000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
66700000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22200000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53200000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
95500000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95800000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94500000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99000000.0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97900000 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1423400000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
68500000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1800000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
43100000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11400000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1544600000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1279200000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
22500000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-300000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37100000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7500000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1346000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1374000000 usd
us-gaap Net Income Loss
NetIncomeLoss
65500000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-12300000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
129600000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20100000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1544600000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1126200000 usd
us-gaap Net Income Loss
NetIncomeLoss
96900000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1400000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
98600000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25700000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1346000000 usd
us-gaap Net Income Loss
NetIncomeLoss
65500000 usd
us-gaap Net Income Loss
NetIncomeLoss
96900000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
129600000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
98600000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-70000000.0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Depreciation
Depreciation
11200000 usd
us-gaap Depreciation
Depreciation
7900000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12100000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1000000.0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
800000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
23600000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-7500000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
5600000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
9000000.0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
3000000.0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
7700000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
115700000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6700000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6500000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2500000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
77000000.0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
37700000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
20700000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
21700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
196400000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
252300000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
387900000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
658700000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
348800000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
523900000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
7700000 usd
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
4600000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14700000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-61500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-153900000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20100000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25700000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
279000000.0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
100000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-258900000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-124000000.0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
124000000.0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344000000.0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
190300000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220000000.0 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
314300000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
700000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
300000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21600000 usd
us-gaap Interest Paid Net
InterestPaidNet
4600000 usd
us-gaap Interest Paid Net
InterestPaidNet
4300000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
4300000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3400000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
595600000 usd
CY2022Q3 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
0 usd
CY2022Q3 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
8400000 usd
CY2022Q3 nbix Debt Securities Available For Sale Fair Value Current
DebtSecuritiesAvailableForSaleFairValueCurrent
587200000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
370600000 usd
CY2021Q4 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxCurrent
0 usd
CY2021Q4 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Current
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxCurrent
100000 usd
CY2021Q4 nbix Debt Securities Available For Sale Fair Value Current
DebtSecuritiesAvailableForSaleFairValueCurrent
370500000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
373100000 usd
CY2022Q3 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
0 usd
CY2022Q3 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
10500000 usd
CY2022Q3 nbix Debt Securities Available For Sale Fair Value Noncurrent
DebtSecuritiesAvailableForSaleFairValueNoncurrent
362600000 usd
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Noncurrent
DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
563200000 usd
CY2021Q4 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent
0 usd
CY2021Q4 nbix Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Noncurrent
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent
2500000 usd
CY2021Q4 nbix Debt Securities Available For Sale Fair Value Noncurrent
DebtSecuritiesAvailableForSaleFairValueNoncurrent
560700000 usd
CY2022Q3 nbix Debt Securities Available For Sale Position Number Of Positions
DebtSecuritiesAvailableForSalePositionNumberOfPositions
193 security
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
183 security
CY2022Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
3900000 usd
CY2021Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
2200000 usd
us-gaap Debt Securities Available For Sale Accrued Interest Writeoff
DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
0 usd
us-gaap Debt Securities Available For Sale Accrued Interest Writeoff
DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
0 usd
CY2022Q3 us-gaap Investments
Investments
1264700000 usd
CY2021Q4 us-gaap Investments
Investments
1338900000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15000000.0 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11200000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5000000.0 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3600000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17000000.0 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15700000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
37000000.0 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
30500000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
212200000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
311100000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7800000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3200000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
220000000.0 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
314300000 usd
CY2022Q1 nbix Lessee Operating Lease Option Term To Construct Fifth Building
LesseeOperatingLeaseOptionTermToConstructFifthBuilding
P6Y
CY2022Q1 nbix Rent Abatement Period
RentAbatementPeriod
P10M
CY2022Q1 nbix Lessee Operating Lease Monthly Base Rent Per Square Foot
LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot
6 usd
CY2022Q1 nbix Annual Rent Escalation Percentage
AnnualRentEscalationPercentage
0.03
CY2022Q1 nbix Number Of Renewal Options
NumberOfRenewalOptions
2 renewaloption
CY2022Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7800000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
12500000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
11200000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
12200000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9100000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y1M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4400000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17900000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17400000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
15900000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15700000 usd
CY2022Q3 nbix Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
70400000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
141700000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
27800000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
113900000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17300000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96600000 usd
CY2022Q3 nbix Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Two
NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearTwo
17200000 usd
CY2022Q3 nbix Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Three
NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearThree
33300000 usd
CY2022Q3 nbix Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Four
NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearFour
41900000 usd
CY2022Q3 nbix Non Cancelable Future Minimum Lease Payments For Operating Leases Not Yet Commenced Year Five
NonCancelableFutureMinimumLeasePaymentsForOperatingLeasesNotYetCommencedYearFive
479700000 usd
CY2022Q3 nbix Debt Instrument Coupon Interest
DebtInstrumentCouponInterest
1000000.0 usd
CY2021Q3 nbix Debt Instrument Coupon Interest
DebtInstrumentCouponInterest
2200000 usd
nbix Debt Instrument Coupon Interest
DebtInstrumentCouponInterest
5000000.0 usd
nbix Debt Instrument Coupon Interest
DebtInstrumentCouponInterest
6300000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
200000 usd
CY2021Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4400000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1000000.0 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12900000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1200000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
6600000 usd
us-gaap Interest Expense
InterestExpense
6000000.0 usd
us-gaap Interest Expense
InterestExpense
19200000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
68500000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68500000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22500000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22500000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
65500000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
65500000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
96900000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
96900000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95800000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94500000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99000000.0 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97900000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4900000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000.0 shares

Files In Submission

Name View Source Status
nbix-20220930_cal.xml Edgar Link unprocessable
nbix-20220930_def.xml Edgar Link unprocessable
nbix-20220930_pre.xml Edgar Link unprocessable
nbix-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0000914475-22-000058-index-headers.html Edgar Link pending
0000914475-22-000058-index.html Edgar Link pending
0000914475-22-000058.txt Edgar Link pending
0000914475-22-000058-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nbix-20220930.htm Edgar Link pending
nbix-20220930.xsd Edgar Link pending
nbix-20220930_g1.jpg Edgar Link pending
q3-2022xexhibit311.htm Edgar Link pending
q3-2022xexhibit312.htm Edgar Link pending
q3-2022xexhibit32.htm Edgar Link pending
nbix-20220930_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending